Intersect ENT was a medical device company based in Menlo Park, California that developed drug-eluting, bioresorbable sinus implants for patients with chronic rhinosinusitis. Its PROPEL family of steroid-eluting implants maintains sinus patency and delivers localized mometasone furoate to the sinus mucosa following endoscopic sinus surgery, while… - View it on GitHub